Interim analyses in clinical trials: classical vs. Bayesian approaches.
暂无分享,去创建一个
[1] F. J. Anscombe. Sequential Medical Trials , 1963 .
[2] B. Brown. Comments on the Dupont manuscript , 1983 .
[3] K McPherson,et al. On choosing the number of interim analyses in clinical trials. , 1982, Experientia. Supplementum.
[4] D A Berry,et al. Statistical inference and the design of clinical trials. , 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.].
[5] P. Canner. Comment on "Statistical inference from clinical trials: choosing the right P value". , 1983, Controlled clinical trials.
[6] D. J. Finney,et al. Introduction to Probability and Statistics , 1968 .
[7] J. Cornfield. Sequential Trials, Sequential Analysis and the Likelihood Principle , 1966 .
[8] P. Canner. Monitoring treatment differences in long-term clinical trials. , 1977, Biometrics.
[9] L. J. Savage,et al. The Foundations of Statistics , 1955 .
[10] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[11] R. Madsen,et al. P values for tests using a repeated significance test design , 1982 .
[12] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[13] M C Weinstein,et al. Allocation of subjects in medical experiments. , 1974, The New England journal of medicine.
[14] W. Dupont. Sequential stopping rules and sequentially adjusted P values: does one require the other? , 1983, Controlled clinical trials.
[15] G A Diamond,et al. Clinical trials and statistical verdicts: probable grounds for appeal. , 1983, Annals of internal medicine.